Abstract:BACKGROUND:Although an alteration in sex hormones has been linked to perfluoroalkyl substances (PFAS) in premenopausal women and girls, whether such associations exist in postmenopausal women remains uncertain. OBJECTS:To examine the associations between serum PFAS concentrations and sex hormone levels in postmenopausal women. METHODS:Data from the National Health and Nutrition Examination Survey (NHANES) 2013-2016 waves were used. A total of 706 postmenopausal women with information on serum PFAS [perfluorohexane sulfonic acid (PFHxS), pefluorodecanoic acid (PFDA); perfluorononanoic acid (PFNA); linear perfluorooctanoate (n-PFOA); linear perfluorooctane sulfonate (n-PFOS); monomethyl branched isomers of PFOS (Sm-PFOS)], sex hormones indicators [e.g., total testosterone (TT), estradiol (E2) and sex hormone binding globulin (SHBG)] as well as selected covariates were included. An indicator of circulating free testosterone (FT), and ratio of TT to E2 (TT/E2) were generated. Multiple linear regression accounting for the primary sampling unit, strata, and environmental sampling weights of PFAS was used for association analyses. Effect modification by obesity and type of menopause was explored via stratified analyses as well as the testing of interaction terms. Principal component analysis (PCA) and Bayesian kernel machine regression (BKMR) were conducted to assess these relationships in a multiple PFAS exposure setting. RESULTS:After adjusting for potential confounders, total perfluorooctanoate (TPFOA: n-PFOA + Sb-PFOA) and total perfluorooctane sulfonate (TPFOS: n-PFOS + Sm-PFOS), and their linear and branched isomers were positively associated with two androgen indicators (i.e., TT and FT). PCA results revealed that the principal component (PC) composed of n-PFOA was positively associated with ln (TT) [β = 0.09, 95% confidential interval (CI): 0.02, 0.16; per ln-ng/mL increase in exposure], and ln (FT) (β = 0.12, 95% CI: 0.05, 0.2) in overweight/obese [body mass index (BMI) ≥ 25 kg/m2] women, but not in those with BMI < 25 kg/m2. Additionally, among overweight/obese women, PFHxS was positively associated with androgens and negatively with ln (SHBG) (β = -0.06, 95% CI: -0.12, -0.01). The PC composed of Sm-PFOS, n-PFOS, and PFHxS was positively associated with ln (TT) levels among overweight/obese women. Results from BKMR also confirmed the findings on n-PFOA and PFHxS. CONCLUSIONS:Our study indicates that n-PFOA and PFHxS were positively associated with levels of several androgen indicators in postmenopausal women, particularly among overweight/obese ones. Given the higher risk of cardiometabolic diseases associated with elevated levels of androgens in postmenopausal women, future studies are needed to explore the potential underlying mechanisms.

Environmental exposure to per- and polyfluoroalkyl substances mixture and male reproductive hormones.

Environmental Exposure to Legacy Poly/perfluoroalkyl Substances, Emerging Alternatives and Isomers and Semen Quality in Men: A Mixture Analysis.

Association Between Per- and Polyfluoroalkyl Substances and Sex Hormone Levels in Males Based on Human Studies

Exposure to Per- and Polyfluoroalkyl Substances (pfass) in Serum Versus Semen and Their Association with Male Reproductive Hormones.

Associations of Per- and Polyfluoroalkyl Substances and Alternatives with Reproductive Hormones in Women of Childbearing Age

Environmental exposure to legacy and emerging per- and polyfluoroalkyl substances and endometriosis in women of childbearing age

Association of Perfluoroalkyl Substances Exposure with Reproductive Hormone Levels in Adolescents: by Sex Status

Environmental Exposure to Emerging Alternatives of Per- and Polyfluoroalkyl Substances and Polycystic Ovarian Syndrome in Women Diagnosed with Infertility: A Mixture Analysis

Association Between Prenatal Exposure to PFAS and Fetal Sex Hormones: Are the Short-Chain PFAS Safer?

Associations of per- and polyfluoroalkyl substances with maternal early second trimester sex-steroid hormones

Association of perfluoroalkyl and polyfluoroalkyl substances with sex hormones in children and adolescents 6–19 Years of age

Associations Between Per- and Polyfluoroalkyl Substances and Menstrual Cycle Regularity in Reproductive-Aged Female: a Cross-Sectional Study

Sex-specific effect of perfluoroalkyl substances exposure on liver and thyroid function biomarkers: A mixture approach

Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.

Perfluoroalkyl Chemicals and Male Reproductive Health: Do PFOA and PFOS Increase Risk for Male Infertility?

Isomer of per- and polyfluoroalkyl substances and red blood cell indices in adults: The Isomers of C8 Health Project in China

Preconception exposure to perfluoroalkyl and polyfluoroalkyl substances and couple fecundity: A couple-based exploration

Per- and polyfluoroalkyl substances (PFAS) and male reproductive function in young adulthood; a cross-sectional study

ASSOCIATIONS BETWEEN PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS) EXPOSURE AND SEMEN QUALITY PARAMETERS AMONG MEN ATTENDING A FERTILITY CLINIC

Assessment of the Emerging Threat Posed by Perfluoroalkyl and Polyfluoroalkyl Substances to Male Reproduction in Humans

Association between polyfluoroalkyl substances exposure and sex steroids in adolescents: The mediating role of serum albumin